Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII-Reference-Cited by-同舟云学术

Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII

Published:1994-03 Issue:3 Volume:86 Page:610-618
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bernardi F.,Liney D. L.,Patracchini P.,Gemmati D.,Legnani C.,Arcieri P.,Pinotti M.,Redaelli R.,Ballerini G.,Pemberton S.,Wacey A. I.,Mariani G.,Tuddenham E. G. D.,Marchetti G.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1994.tb04793.x/fullpdf

Reference39 articles.

1. THE EFFECTS OF ADRENOCORTICOTROPIC HORMONE AND CORTISONE IN THE ADRENOGENITAL SYNDROME ASSOCIATED WITH CONGENITAL ADRENAL HYPERPLASIA: AN ATTEMPT TO EXPLAIN AND CORRECT ITS DISORDERED HORMONAL PATTERN 12

2. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.

3. Factor IX is activated in vivo by the tissue factor mechanism

4. Structure and mechanism of chymotrypsin

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency;Seminars in Thrombosis and Hemostasis;2024-08-29

2. Utility of ACMG classification to support interpretation of molecular genetic test results in patients with factor VII deficiency;Frontiers in Medicine;2023-07-14

3. Extensive genetic screening of Iranian Factor FVII-deficient individuals unraveled several novel mutations and postulated founder effects in some cases;Research and Practice in Thrombosis and Haemostasis;2023-01

4. Molecular spectrum of inherited FVII deficiency in North India revealed a recurrent variant with a founder effect;Haemophilia;2022-12-26

5. Thrombotic Events in Homozygotes with a Proven or Highly Probable Arg304Gln Factor VII Mutation (FVII Padua)1): Only Limited Replacement Therapy is Needed in Case of Surgery;Cardiovascular & Hematological Disorders-Drug Targets;2019-10-21